Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Inhibrx, Inc. (INBX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
28 Aug 2023
VIKING GLOBAL INVESTORS LP
10% Owner
Inhibrx, Inc.
(INBX)
511,627
+100%
511,627
$19.35
$9,899,983.00
SELL
1 Mar 2023
Eckelman Brendan P.
Chief Scientific Officer, Officer
Inhibrx, Inc.
(INBX)
2,035,953
-1%
40,000
$24.21
$968,230.75
SELL
28 Feb 2023
Lappe Mark
Chief Executive Officer, Director, Officer
Inhibrx, Inc.
(INBX)
2,486,192
-0%
60
$25.02
$1,501.25
SELL
1 Feb 2023
Eckelman Brendan P.
Chief Scientific Officer, Officer
Inhibrx, Inc.
(INBX)
2,076,683
-1%
40,000
$24.93
$997,210.10
SELL
23 Jan 2023
Kayyem Jon Faiz
Director
Inhibrx, Inc.
(INBX)
3,224,301
-0%
9,500
$25.26
$239,999.45
SELL
23 Jan 2023
Lappe Mark
Chief Executive Officer, Director, Officer
Inhibrx, Inc.
(INBX)
2,486,315
-1%
26,000
$25.42
$660,842.00
SELL
3 Jan 2023
Eckelman Brendan P.
Chief Scientific Officer, Officer
Inhibrx, Inc.
(INBX)
2,118,556
-1%
40,000
$23.71
$948,598.40
SELL
21 Dec 2022
Kayyem Jon Faiz
Director
Inhibrx, Inc.
(INBX)
3,235,760
-0%
9,500
$27.02
$256,679.02
SELL
19 Dec 2022
Lappe Mark
Chief Executive Officer, Director, Officer
Inhibrx, Inc.
(INBX)
2,513,006
-1%
26,000
$25.56
$664,443.40
SELL
6 Dec 2022
Eckelman Brendan P.
Chief Scientific Officer, Officer
Inhibrx, Inc.
(INBX)
2,174,626
-1%
40,000
$27.22
$1,088,682.80
SELL
21 Nov 2022
Kayyem Jon Faiz
Director
Inhibrx, Inc.
(INBX)
3,250,068
-0%
9,500
$29.89
$283,972.47
SELL
17 Nov 2022
Lappe Mark
Chief Executive Officer, Director, Officer
Inhibrx, Inc.
(INBX)
2,557,293
-1%
26,000
$27.88
$724,909.75
SELL
1 Nov 2022
Eckelman Brendan P.
Chief Scientific Officer, Officer
Inhibrx, Inc.
(INBX)
2,207,902
-1%
40,000
$33.51
$1,340,387.00
SELL
21 Oct 2022
Kayyem Jon Faiz
Director
Inhibrx, Inc.
(INBX)
3,258,729
-0%
9,500
$30.13
$286,231.70
SELL
17 Oct 2022
Lappe Mark
Chief Executive Officer, Director, Officer
Inhibrx, Inc.
(INBX)
2,581,271
-0%
26,000
$29.59
$769,443.25
BUY
7 Oct 2022
VIKING GLOBAL INVESTORS LP
10% Owner
Inhibrx, Inc.
(INBX)
2,427,307
+121%
1,333,333
$30.00
$39,999,856.00
SELL
4 Oct 2022
Eckelman Brendan P.
Chief Scientific Officer, Officer
Inhibrx, Inc.
(INBX)
2,274,105
-1%
40,000
$27.82
$1,112,813.20
SELL
6 Sep 2022
Eckelman Brendan P.
Chief Scientific Officer, Officer
Inhibrx, Inc.
(INBX)
2,438,046
-1%
40,000
$14.91
$596,273.60
SELL
2 Aug 2022
Eckelman Brendan P.
Chief Scientific Officer, Officer
Inhibrx, Inc.
(INBX)
2,475,553
-1%
40,000
$18.00
$719,834.50
SELL
7 Jul 2022
Eckelman Brendan P.
Chief Scientific Officer, Officer
Inhibrx, Inc.
(INBX)
2,515,553
-1%
40,000
$17.17
$686,800.00
SELL
5 Apr 2022
Eckelman Brendan P.
Chief Scientific Officer, Officer
Inhibrx, Inc.
(INBX)
2,555,553
-0%
400
$25.04
$10,016.00
SELL
24 Mar 2021
Eckelman Brendan P.
Chief Scientific Officer, Director, Officer
Inhibrx, Inc.
(INBX)
2,555,953
-0%
17,000
$19.02
$323,340.00
SELL
16 Feb 2021
Wagner Klaus W.
Chief Medical Officer, Officer
Inhibrx, Inc.
(INBX)
215,150
-45%
176,033
$24.43
$4,300,095.00
SELL
16 Feb 2021
Eckelman Brendan P.
Chief Scientific Officer, Director, Officer
Inhibrx, Inc.
(INBX)
2,572,953
-0%
17,000
$25.90
$440,300.00
BUY
26 Aug 2020
VIKING GLOBAL INVESTORS LP
10% Owner
Inhibrx, Inc.
(INBX)
1,327,307
+15%
180,219
$18.92
$3,409,865.50
BUY
21 Aug 2020
VIKING GLOBAL INVESTORS LP
10% Owner
Inhibrx, Inc.
(INBX)
1,176,609
+12%
131,465
$19.39
$2,548,688.00
Home